EPIRUBICIN for Osteosarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where EPIRUBICIN was used for Osteosarcoma.
Most Reported Side Effects for EPIRUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 1,265 | 7.8% | 84 | 456 |
| Vomiting | 978 | 6.0% | 77 | 379 |
| Myelosuppression | 934 | 5.7% | 15 | 497 |
| Neutropenia | 926 | 5.7% | 93 | 304 |
| White blood cell count decreased | 873 | 5.4% | 10 | 286 |
| Febrile neutropenia | 809 | 5.0% | 112 | 504 |
| Diarrhoea | 749 | 4.6% | 97 | 381 |
| Asthenia | 732 | 4.5% | 38 | 341 |
| Pyrexia | 729 | 4.5% | 65 | 500 |
| Fatigue | 685 | 4.2% | 56 | 215 |
| Death | 684 | 4.2% | 683 | 43 |
| Alopecia | 606 | 3.7% | 109 | 71 |
| Off label use | 592 | 3.6% | 100 | 181 |
| Disease progression | 539 | 3.3% | 147 | 62 |
| Anaemia | 535 | 3.3% | 63 | 187 |
Other Indications for EPIRUBICIN
Breast cancer (5,444)
Breast cancer female (1,236)
Triple negative breast cancer (1,087)
Chemotherapy (840)
Product used for unknown indication (722)
Invasive ductal breast carcinoma (678)
Diffuse large b-cell lymphoma (549)
Breast cancer metastatic (454)
Her2 positive breast cancer (392)
Gastric cancer (381)
Other Drugs Used for Osteosarcoma
METHOTREXATE (1,267)
DOXORUBICIN (1,135)
CISPLATIN (975)
IFOSFAMIDE (845)
ETOPOSIDE (531)
CARBOPLATIN (169)
CABOZANTINIB S-MALATE (116)
DOCETAXEL (99)
CYCLOPHOSPHAMIDE (92)
LENVATINIB (91)